IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.360
0.00 (0.00%)
At close: Jun 26, 2026, 4:00 PM EDT
1.370
+0.010 (0.74%)
After-hours: Jun 26, 2026, 6:09 PM EDT
IN8bio Employees
IN8bio had 17 employees as of December 31, 2025. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,054,444
Market Cap
13.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 24 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| Jasper Therapeutics | 22 |
| BioCardia | 21 |
| BioVie | 13 |
| Cocrystal Pharma | 10 |
| Lexaria Bioscience | 7 |
INAB News
- 23 days ago - IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies - GlobeNewsWire
- 25 days ago - IN8bio Slides: Corporate presentation - Filings
- 25 days ago - IN8bio announces updated INB-200, INB-400 study data - TheFly
- 25 days ago - IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026 - GlobeNewsWire
- 5 weeks ago - IN8bio Transcript: R&D Day 2026 - Transcripts
- 5 weeks ago - IN8bio Slides: FY 2026 - Filings
- 5 weeks ago - IN8bio Registration statement: Registration filing - Filings
- 7 weeks ago - IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire